Temporal changes and regional differences in treatment uptake of hepatitis C therapy in EuroSIDA

Publikation: Bidrag til tidsskriftTidsskriftartikelForskning

  • D Grint
  • L Peters
  • C Schwarze-Zander
  • M Beniowski
  • C Pradier
  • M Battegay
  • D Jevtovic
  • V Soriano
  • Lundgren, Jens
  • J K Rockstroh
  • Kirk, Ole
  • A Mocroft
  • EuroSIDA in EuroCoord
All HIV/hepatitis C virus (HCV)-coinfected patients with chronic HCV infection and ≥ F2 fibrosis should be considered for HCV therapy. This study aimed to determine the rate of HCV treatment uptake among coinfected patients in Europe.
OriginalsprogEngelsk
TidsskriftHIV Medicine
Vol/bind14
Udgave nummer10
Sider (fra-til)614-23
Antal sider10
ISSN1464-2662
DOI
StatusUdgivet - nov. 2013

ID: 93934717